Heidelberg Engineering announced that the Food and Drug Administration (FDA) has cleared the latest Spectralis software version, which is designed to deliver speed, workflow flexibility, and diagnostic depth to multimodal retinal imaging.  

According to Heidelberg, the latest release of Spectralis with SHIFT Technology introduces 250 kHz scan speed for optical coherence tomography angiography (OCTA) imaging, complementing the existing 85 kHz and 125 kHz scan speeds. Supported by enhanced TruTrack Active Eye Tracking, the 250 kHz speed delivers the fastest OCTA image acquisition yet on Spectralis, accelerating OCTA workflows in clinical practice. SHIFT technology's multi-speed approach also allows clinicians to tailor imaging to specific workflow demands and clinical needs, balancing acquisition time and image detail for each patient, the company said in a press release.

In addition, the Green Autofluorescence module improves visualization of the macula by enabling identification of key features, such as foveal sparing in macular atrophy. According to the company, this clarity allows for confident diagnosis, patient selection, and disease monitoring, while compatibility with RegionFinder enables quantification of atrophy for clinical assessment and longitudinal analysis. The combination of Green Autofluorescence and BluePeak blue autofluorescence imaging provides a comprehensive view of retinal structure and metabolic changes. 

Additional features further support clinical workflow, patient comfort, and advanced imaging capabilities.  Commercial launch is planned for the second half of the year, the company said. RP